Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere
about
Understanding the regulation of Group B Streptococcal virulence factorsMolecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distributionStreptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts.Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.Group B Streptococcus prophylaxis in patients who report a penicillin allergy: a follow-up study.Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital.Identification of a novel keyhole phenotype in double-disk diffusion assays of clindamycin-resistant erythromycin-sensitive strains of Streptococcus agalactiae.Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model.Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections.Transplacental passage of vancomycin in the ex vivo human perfusion model.Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea.Type IV neonatal early-onset group B streptococcal disease in a United States hospital.Prevention of neonatal group B streptococcal disease: progress, challenges and dilemmas.Preventing group B streptococcal infections: new recommendations.Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central AfricaUpdate on clindamycin in the management of bacterial, fungal and protozoal infections.Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina.Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease.Early-onset neonatal group B streptococcal infections in New Zealand 1998-1999.Antimicrobial susceptibility of group B streptococci collected in two Belgian hospitals.Antimicrobial susceptibility of invasive group B streptococcal isolates from south-west Sweden 1988-2001.Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea
P2860
Q28237019-CD3B1946-6A70-48B9-85CC-1518D88D94BEQ33187309-4F715E38-216B-420F-84E4-AF30D5CAD9A8Q33628628-DCE3C239-67FF-44BB-829B-71D000A76FB3Q33755459-4D414488-CE26-4B4E-824F-30FE321B0150Q33771867-C2961246-B446-47E4-BB68-0F9A9D96ACCAQ33982390-4F0D65B4-136F-4B6B-94B8-0D4201089A96Q33983637-E9234CFC-F835-4AC7-8394-069F51CE2922Q34231603-31236973-2986-46DA-9FD8-0C8EEBA6411DQ34433251-58165801-A71C-4A98-9CF4-5ACD8B5D7E27Q34571597-B17DB43B-6DAE-484C-8D74-3E0B543B5713Q34735517-759DEBB8-03FB-4F60-9F50-7142F2175F7FQ34822471-73D99941-A397-4E04-B7F8-D2A241ADBBB5Q35072617-E58C0F4D-9678-40AB-939A-01D0DBD8E860Q35125919-3EFA9799-C6E0-478F-8B84-9E81336CD6F9Q35541855-4A39914B-629D-455E-B365-7176A3AB6AE7Q35547508-5AC11CDB-D620-40EE-A17E-5822397D0E5EQ35614548-37D29BFB-DF2E-46A1-ACA3-1CC158155BC9Q35712918-8FF2FB94-C6BC-4A85-863A-B4D48C2EDC80Q35784351-9C2C1148-69C6-4257-98AF-1BEA6D6319E4Q35966164-93CF0014-2235-4D60-AEEC-7BE1461E60A0Q36170559-6E97D2CA-1ADA-40B0-9373-9D849DB676EDQ36316713-56FC3979-F67A-4208-B749-522C2D99FCBFQ36967293-86AC3116-0347-445E-87FB-0C0F84CA68D7Q37159137-D324F0FE-55EB-4AF3-85AC-1D2DE8EDD73BQ38844623-B747877C-1495-4BC1-9691-5ACED48B67F9Q40581083-5A32D610-0430-4340-BB7C-01C0438909C9Q44915009-2FAA8A08-7D07-4A77-8312-A0DDADE572A9Q46965103-767D355F-21EC-4AF2-9157-81A1A525DB6DQ57213960-8C23A94D-2339-4045-9E0A-DDE2F63C7AFA
P2860
Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere
description
im Oktober 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2000
@uk
name
Group B streptococci causing n ...... ters in the Western Hemisphere
@en
Group B streptococci causing n ...... ters in the Western Hemisphere
@nl
type
label
Group B streptococci causing n ...... ters in the Western Hemisphere
@en
Group B streptococci causing n ...... ters in the Western Hemisphere
@nl
prefLabel
Group B streptococci causing n ...... ters in the Western Hemisphere
@en
Group B streptococci causing n ...... ters in the Western Hemisphere
@nl
P2093
P356
P1476
Group B streptococci causing n ...... ters in the Western Hemisphere
@en
P2093
P304
P356
10.1067/MOB.2000.108839
P407
P577
2000-10-01T00:00:00Z